Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Prolactin levels are higher in women with hirsutism but don't relate to its severity.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Excessive hair growth is much more common in Chinese women with PCOS than in the general population.

Higher anxiety levels are linked to sexual dysfunction in women with PCOS.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Efficient PCOS screening is crucial for early detection, with lifestyle factors like fruit intake potentially aiding prevention.

More body hair in young Australian women is linked to higher androstenedione levels.

Both oral contraceptives reduced hirsutism in PCOS patients, but adding metformin showed no extra benefit.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Treat significant hirsutism with medication and hair removal; use birth control pills first, adding antiandrogens if needed.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Skin issues might be linked to infertility.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.